Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Baby's nose bugs may predict asthma risk

NCT ID NCT01978288

Knowledge-focused Sponsor: Indiana University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 180 infants from birth to age 2 to see how bacteria in their upper airways change over time. Researchers want to learn if certain bacteria lead to more airway inflammation and lower lung function, which could increase asthma risk. The study does not test any treatment, but aims to better understand how asthma develops.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 180 people

The number the study aims to enrol. It can still change while the study runs.

Start date

Jan 2014

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Infants whose mother has asthma; Infants whose parents are without atopy - asthma, eczema, seasonal allergies

Ages

1 minute to 1 week

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Moms age 14 and older (will sign Informed Consent Statement (ICS), not an assent) 2. Mother of child enrolled must have a physician diagnosis of asthma or being treated for asthma (for 140 subjects; 40 subjects will be recruited from mothers and fathers without atopy - asthma, eczema, seasonal allergies) 3. Child must be enrolled during first week of life 4. Signed informed consent from parent(s) or legal guardian(s) Exclusion Criteria: 1. Child has a history of wheezing or underlying lung disease 2. Respiratory complications at birth (airway support higher then nasal cannula) 3. Born earlier then 37 weeks gestation 4. Congenital heart defects (not including Patent Ductus Arteriosus (PDA), hemodynamically insignificant Ventricular Septal Defect (VSD) or Atrial Septal Defect (ASD) 5. Underlying neuromuscular disease 6. Severe upper airway obstruction, sleep apnea, tracheomalacia, or laryngomalacia 7. Hydrocephalus 8. History of seizures 9. History of arrhythmia and baseline oxygenation level \<90% on room air 10. Infant is non-viable 11. Severe gastroesophageal reflux 12. Prior chest surgery or structural abnormalities of the lungs or chest wall 13. Has a history of adverse reaction to chloral hydrate 14. Ward of the state 15. Any physical finding(s) that would compromise the safety of the subject or the quality of the study data as determined by the site investigator

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Asthma are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

asthma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Asthma

Contacts and locations

Locations

  • Riley Hospital for Children at Indiana University Health

    Indianapolis, Indiana, 46202, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.